Market News / Story
Perspective Therapeutics Granted Fast Track Designation for [212Pb]PSV359 for the Treatment of Adult Patients with Locally Advanced Unresectable an…
GlobeNewswire ·
GlobeNewswire reports: SEATTLE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that the U.S. Food and Drug Administration (the “FDA”) granted Fast Track Designation for the development of PSV359 for adult patients with locally advanced unresectable and/or metastatic fibroblast…
Related stories
Higher bond yields are raising the bar for stocks: Stan WongRead story summary
For much of this year, “higher for longer” was a warning. Now it is a market reality. With the U.S. 10-year Treasury yield above 5.25 per cent and touching a two-decade high, borrowing costs are becoming harder for markets to ignore. Bonds also compete more directly with equities for investor capital. The implications for equity valuations are significant. ...
VIEW SOURCE
ECB's Dolenc: Persistently Elevated Inflation Supports The Case For Moving Policy Rates Towards A More Restrictive TerritoryRead story summary
ECBs Dolenc: Risks Skewed To The Upside On Oil, Gas, Food, Strong Growth - Persistently Elevated Inflation Supports The Case For Moving Policy Rates Towards A More Restrictive Territory - More Stable Core Provides Some Reassurance That Broader Price Pressures Contained Ecb's Dolenc: Inflation Risks Skewed To The Upside On Oil, Gas, Food, Strong Growth ; More Stable Core Provides Some Reassurance That Broader Price Pressures Contained #oott
VIEW SOURCE
India’s central bank hikes rates for the first time since 2023 as inflation risks buildRead story summary
The Reserve Bank of India on Wednesday raised interest rates for the first time since 2023, joining several major central banks in tightening monetary policy to arrest accelerating inflation. The central bank increased the benchmark repo rate by 25 basis points to a 1-year high of 5.50%, in line with expectations of economists polled by Reuters. India’s ...
VIEW SOURCE